iPS cells in the study of PD molecular pathogenesis

Cell Tissue Res. 2018 Jul;373(1):61-77. doi: 10.1007/s00441-017-2749-y. Epub 2017 Dec 12.


Parkinson's disease (PD) is the second most common neurodegenerative disease and its pathogenic mechanisms are poorly understood. The majority of PD cases are sporadic but a number of genes are associated with familial PD. Sporadic and familial PD have many molecular and cellular features in common, suggesting some shared pathogenic mechanisms. Induced pluripotent stem cells (iPSCs) have been derived from patients harboring a range of different mutations of PD-associated genes. PD patient-derived iPSCs have been differentiated into relevant cell types, in particular dopaminergic neurons and used as a model to study PD. In this review, we describe how iPSCs have been used to improve our understanding of the pathogenesis of PD. We describe what cellular and molecular phenotypes have been observed in neurons derived from iPSCs harboring known PD-associated mutations and what common pathways may be involved.

Keywords: Alpha-synuclein; Autophagy; Induced pluripotent stem cell (iPSC); Neurodegeneration; Parkinson’s disease.

Publication types

  • Review

MeSH terms

  • Animals
  • Environment
  • Humans
  • Induced Pluripotent Stem Cells / metabolism*
  • Models, Biological
  • Nerve Tissue Proteins / metabolism
  • Parkinson Disease / genetics*
  • Parkinson Disease / immunology
  • Parkinson Disease / pathology*
  • Signal Transduction


  • Nerve Tissue Proteins